Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2020 Jul 24;12(8):2203.
doi: 10.3390/nu12082203.

A Dairy Product to Reconstitute Enriched with Bioactive Nutrients Stops Bone Loss in High-Risk Menopausal Women without Pharmacological Treatment

Affiliations
Randomized Controlled Trial

A Dairy Product to Reconstitute Enriched with Bioactive Nutrients Stops Bone Loss in High-Risk Menopausal Women without Pharmacological Treatment

Marina Morato-Martínez et al. Nutrients. .

Abstract

Osteoporosis is a multifactorial disease characterized by the loss of bone mass and deterioration of the internal structure of the bone, increasing the risk of fractures, and is becoming an economic and social problem. The main treatment is pharmacological, however, the population demands other therapies, such as foods with nutrients beneficial to bone health. Seventy-eight healthy menopausal women at risk of osteoporosis or untreated osteopenia were recruited for a randomized, parallel, double-blind clinical trial with two intervention groups: one group consumed a serving a day of the experimental enriched product (experimental group (EG)) and the other group (control group (CG)) consumed the same product without enrichment. The main objective was to compare the effect of consuming a dairy preparation to reconstitute, similar to yogurt when prepared, enriched in calcium, vitamin D, vitamin K, vitamin C, zinc, magnesium, L-leucine and probiotic (Lactobacillus plantarum 3547) on bone metabolism markers for 24 weeks. The EG showed a significantly increased bone mass compared to the CG (0.01 ± 0.03 vs. -0.01 ± 0.03 kg; p < 0.05). In addition, the EG maintained their bone mineral density (BMD) compared to the CG, whose BMD significantly decreased at the end of the study. For biochemical markers, the EG significantly increased the serum levels of the N-terminal propeptide of type I collagen (P1NP) bone formation marker (13.19 ± 25.17 vs. -4.21 ± 15.62 ng/mL; p < 0.05), and decreased the carbo-terminal telopeptide of type I collagen (CTx) bone resorption marker compared to the CG (-0.05 ± 0.19 vs. 0.04 ± 0.14 ng/mL; p < 0.05). On the other hand, the EG exhibited a significantly decreased systolic and diastolic blood pressure compared to the start of the study. Finally, the EG significantly increased their dietary calcium and vitamin D intake compared to the CG. In conclusion, the regular consumption of a dairy product to reconstitute enriched with bioactive nutrients improves bone health markers in menopausal women at risk of osteoporosis without pharmacological treatment.

Keywords: bone mineral density; functional foods; nutrition; osteoporosis; prevention.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flow chart describing the present trial.

Similar articles

Cited by

References

    1. National Institutes of Health NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy, March 7–29, 2000: Highlights of the Conference. South. Med. J. 2001;94:569–573. - PubMed
    1. Pouresmaeili F., Dehghan B.K., Kamarehei M., Goh Y.M. A comprehensive overview on osteoporosis and its risk factors. Ther. Clin. Risk Manag. 2018;14:2029–2049. doi: 10.2147/TCRM.S138000. - DOI - PMC - PubMed
    1. Alibasic E., Ljuca F., Brkic S., Fazlic M., Husic D. Secondary Prevention of Osteoporosis through Assessment of Individual and Multiple Risk Factors. Mater. Socio Medica. 2020;32:10–14. doi: 10.5455/msm.2020.32.10-14. - DOI - PMC - PubMed
    1. Herrera A., Mateo J., Gil-Albarova J., Lobo-Escolar A., Artigas J.M., López-Prats F., Mesa M., Ibarz E., Gracia L. Prevalence of osteoporotic vertebral fracture in Spanish women over age 45. Maturitas. 2015;80:288–295. doi: 10.1016/j.maturitas.2014.12.004. - DOI - PubMed
    1. Borgström F., Karlsson L., Ortsäter G., Norton N., Halbout P., Cooper C., Lorentzon M., McCloskey E.V., Harvey N.C., Javaid M.K., et al. Fragility fractures in Europe: Burden, management and opportunities. Arch. Osteoporos. 2020;15:59. doi: 10.1007/s11657-020-0706-y. - DOI - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources